Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Tirzepatide is a once-weekly injectable, dual glucagon-like peptide 1 (GLP-1) receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
One vial means one reconstitution, one fill volume and one solution, which eliminates a transfer step along with its sterility and volumetric error from a combined-preparation design, and it means both components share a single reconstitution date and a single in-use window
Reconstitution and storage Proper peptide handling maintains potency throughout your protocol
Dysregulation of these systems is commonly associated with organ-specific lesions in experimental models
Clear calculations help protect solution strength during daily laboratory use
